<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03422562</url>
  </required_header>
  <id_info>
    <org_study_id>REB16-0542</org_study_id>
    <nct_id>NCT03422562</nct_id>
  </id_info>
  <brief_title>Probiotics and Intestinal Microbiome in Preterm Infants</brief_title>
  <official_title>Do Probiotics Modulate the Intestinal Microbiome of Extremely Preterm Infants?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Harish Amin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Calgary</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The gut microbiome plays a significant role in balancing the inflammatory system in the
      immature gut. A breakdown in this balance with altered colonization of the microbiota in very
      low birth weight (VLBW) preterm infants is associated with increased feeding intolerance,
      necrotizing enterocolitis (NEC) and sepsis. Probiotics are proposed to normalize microbial
      populations and decrease intestinal disease in preterm infants. There is limited data linking
      clinical outcomes with the biology of probiotics. We aim to study the colonization of the GI
      tract with probiotic species contained in a specific probiotic blend - Florababy - in VLBW
      preterm infants.

      Stool microbiome will be analyzed at 4 time points in 2 groups (one given Florababy and the
      other no) of infants less than 1000 grams birth weight and &lt; 29 weeks gestation. A comparison
      of stool microbiome analysis and the incidence of feeding intolerance and time to reach full
      feeds in the two groups will be made.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 26, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Blinded, placebo controlled, randomized clinical trial</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stool Microbiome</measure>
    <time_frame>4 weeks</time_frame>
    <description>difference in stool microbiome after Florababy or no drug administration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stool Microbiome</measure>
    <time_frame>2 weeks</time_frame>
    <description>difference in stool microbiome after Florababy or no drug administration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feeding intolerance</measure>
    <time_frame>4-6 weeks</time_frame>
    <description>Incidence of feeding intolerance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Full Feeds</measure>
    <time_frame>4-6 weeks</time_frame>
    <description>Time to reach full feeds.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Microbial Colonization</condition>
  <arm_group>
    <arm_group_label>Probiotic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Florababy probiotic (0.5g per day) will be started at or after 72 hours of life and will be administered in 1ml sterile water prior to feed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of care arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Florababy</intervention_name>
    <description>Probiotic supplement</description>
    <arm_group_label>Probiotic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants born less than 29 weeks gestation and &lt;1000 g birth weight admitted to the
             Neonatal Intensive Care Unit (NICU) at Foothills Medical Centre in Calgary.

        Exclusion Criteria:

          -  Infants with major congenital anomalies, hypoxic-ischemic injury, NEC or bowel
             perforation before 72 hours of life.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>23 Weeks</minimum_age>
    <maximum_age>29 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Harish J Amin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Calgary</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Harish J Amin, MD</last_name>
    <phone>403-944-1615</phone>
    <email>harish.amin@ahs.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Belal Alshaikh, MD</last_name>
    <phone>403-955-2320</phone>
    <email>belal.alshaikh@ahs.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Foothills Medical Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N2T9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Belal Alshaikh, MD</last_name>
      <phone>403-955-2320</phone>
      <email>belal.alshaikh@ahs.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 10, 2018</study_first_submitted>
  <study_first_submitted_qc>February 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2018</study_first_posted>
  <last_update_submitted>February 2, 2018</last_update_submitted>
  <last_update_submitted_qc>February 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Calgary</investigator_affiliation>
    <investigator_full_name>Harish Amin</investigator_full_name>
    <investigator_title>Neonatologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infection</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

